Kim Forest Enterprise Co Ltd
TWSE:6645
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kim Forest Enterprise Co Ltd
TWSE:6645
|
TW |
|
M
|
Max Heights Infrastructure Ltd
BSE:534338
|
IN |
Kim Forest Enterprise Co Ltd
Kim Forest Enterprise Co., Ltd. engages in sale of instruments and reagents needed for new drug research and development. The company is headquartered in Taipei, New Taipei. The company went IPO on 2017-08-18. The firm operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.
Kim Forest Enterprise Co., Ltd. engages in sale of instruments and reagents needed for new drug research and development. The company is headquartered in Taipei, New Taipei. The company went IPO on 2017-08-18. The firm operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.